Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients

BACKGROUND: With essentially no drug available to control the infection caused by the extensively drug-resistant Acinetobacter baumannii (XDR-Ab) in infants and young children, this study explored the clinical outcomes of pediatric patients with drug-resistant XDR-Ab who were treated with rifampicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinlan, Yang, Yifeng, Xiang, Kun, Li, David, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901084/
https://www.ncbi.nlm.nih.gov/pubmed/31819924
http://dx.doi.org/10.24015/JAPM.2018.0072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901084/
https://www.ncbi.nlm.nih.gov/pubmed/31819924
http://dx.doi.org/10.24015/JAPM.2018.0072

Ejemplares similares